Low‐dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial

BACKGROUND: Desoxycorticosterone pivalate (DOCP) is a commonly used mineralocorticoid replacement for dogs with primary hypoadrenocorticism (HA), but manufacturer‐recommended dosing protocols can be cost‐prohibitive. Recent reports also have raised concerns that label dose protocols could be excessi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Vet Intern Med
Autores principales: Vincent, Alysha M., Okonkowski, Linda K., Brudvig, Jean M., Refsal, Kent R., Berghoff, Nora, Olivier, N. Bari, Langlois, Daniel K.
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Inc. 2021
Materias:
SMALL ANIMAL
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8295656/
https://ncbi.nlm.nih.gov/pubmed/34114259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.16195
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares